Helicobacter pylori Infection Increases the Risk of Peptic Ulcers in Chronic Users of Non-steroidal Anti-inflammatory Drugs

References

• Taha A S, Russell R I. Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut 1993; 34: 580–3
   PubMedGoogle Scholar
• Graham D Y, Lidsky M D, Cox A M, Evans D J, Jr, Evans D F, Alpert L, et al. Long-term non-steroidal anti-inflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1653–7
   PubMed Web of Science ®Google Scholar
• Loeb D S, Talley N J, Ahlquist D A, Carpenter H A, Zinsmeister A R. Long-term non-steroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992; 102: 1899–905
   PubMed Web of Science ®Google Scholar
• Martin D F, Montgomery E, Dobek A S, Patrissi G A, Peura D A. Campylobacter pylori, NSAIDs, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268–72
   PubMed Web of Science ®Google Scholar
• Hudson N, Taha A S, Sturrock R D, Russell R I, Hawkey C J. The influence of Helicobacter pylori colonisation on gastroduodenal ulceration in patients on non-steroidal antiinflammatory drugs. Gut 1992; 33(Suppl 1)S42
   Google Scholar
• Shallcross T M, Rathbone B J, Wyatt J I, Heatley R V. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1990; 4: 515–22
   PubMed Web of Science ®Google Scholar
• Iglehart I W, Edlow D W, III, Mills L, Jr, Morrison S A, Hochberg M C. The presence of Campylobacter pylori in nonsteroidal anti-inflammatory drug associated gastritis. J Rheumatol 1989; 16: 599–603
   PubMed Web of Science ®Google Scholar
• Safe A F, Warren B, Corfield A, McNulty C A, Watson B, Mountford R A, et al. Helicobacter pylori infection in elderly people: Correlation between histology and serology. Age Ageing 1993; 22: 215–20
   PubMedGoogle Scholar
• Jones S TM, Clague R B, Eldridge J, Jones D M. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol 1991; 30: 16–20
   PubMedGoogle Scholar
• Mitchell H M, Li Y Y, Hu P J, Li Q, Chen M, Du G G, et al. Epidemiology of Helicobacter pylori in Southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992; 166: 149–53
   PubMed Web of Science ®Google Scholar
• Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311–5
   Google Scholar
• Hosking S W, Ling T KW, Chung S CS, Yung M Y, Cheng A FB, Sung J JY, et al. Eradicating Helicobacter pylori heals duodenal ulcers without anti-secretory therapy: a randomized controlled trial. Lancet 1994; 343: 508–10
   PubMed Web of Science ®Google Scholar
• Sung J JY, Chung S CS, Ling T KW, Yung M Y, Leung V KS, Ng E KW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139–42
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Klein P D, et al. Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence. Ann Intern Med 1992; 116: 705
   PubMed Web of Science ®Google Scholar
• Rauws A J, Tytgat G NJ. Eradication of H. pylori cures denal ulcers. Lancet 1990; 335: 1233–5
   PubMed Web of Science ®Google Scholar
• Taha A S, Kelly R W, Gemmell C G, Les F E, Russell R I. The interaction between Helicobacter pylori culture filtrate and indomethacin effects on the integrity of human gastric antral mucosa and its prostagladins E2 production in vitro. Aliment Pharmacol Ther 1990; 4: 265–73
   PubMedGoogle Scholar
• Kim J G, Graham D Y. Misoprostol Study Group. Helicobacter pylori infection and development of gastric or duodenal ulcers in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994; 89: 203–7
   PubMedGoogle Scholar
• Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 1988; 27: 113–6
   PubMedGoogle Scholar
• Goggin P M, Collins D A, Jazrawi R P, Jackson P A, Corbishley C M, Bourke B E, et al. Prevalence of Helicobacter pylori infection and its effect or symptoms and non-steroidal antiinflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993; 34: 1677–80
   PubMed Web of Science ®Google Scholar
• Gubbins G P, Schubert T T, Attanasio F, Lubetsky M, Perez-Perez G I, Blaser M. Helicobacter pylori seroprevalence in patients with rheumatoid arthritis: effect of non-steroidal anti-inflammatory drugs and gold compounds. Am J Med 1992; 93: 412–8
   PubMedGoogle Scholar
• Doube A, Morris A. Non-steroidal anti-inflammatory drug-induced dyspepsia is Campylobacter pyloridis implicated. Br J Rheumatol 1988; 27: 110–2
   PubMedGoogle Scholar
• Taha A S, Boothman P, Nakshabendi I, Reid J, Morran C, Gemmell C G, et al. Diagnostic tests for Helicobacter pylori-comparison and influence of non-steroidal anti-inflammatory drugs. J Clin Pathol 1992; 45: 135–9
   PubMedGoogle Scholar
• Sung J JY, Ling T KW, Suen R, Leung V KS, Ng E KW, Chung S CS. Amoxicillin plus omeprazole versus triple therapy for the eradication of H. pylori and healing of duodenal ulcers. Gut 1995; 37(Suppl 1)A6
   Google Scholar
• Kang J Y, Wee A, Math M V, Guan R, Tay H H, Yap I, et al. Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore. Gut 1990; 31: 850–3
   PubMed Web of Science ®Google Scholar
• Laine L, Marin-Sotensen M, Weinstein W M. Helicobacter pylori prevalence and mucosal injury in gastric ulcers: relationship to chronic non-inflammatory drug ingestion. Gastroenterol 1991; 100: A103
   Google Scholar
• Taylor D N, Blaser M J. The epidemiology of Helicobacter pylori infection. Helicobacter pylori in peptic ulceration and gastritis, B J Marshall, R W McCallum, R Guerrant. Blackwell Scientific Publication, Cambridge 1991; 46–54
   Google Scholar
• Caselli M, Pazzi P, La Corte R, Aleotti A, Trevisani L, Stabellini G. Campylobacter-lHae organisms, non-steroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion 1989; 44: 101–4
   PubMed Web of Science ®Google Scholar
• Mohamed A H, Carter A, Wilkinson J, Barrientos M, Hung R H. Long-term strategies to prevent duodenal ulcer (DU): a meta-analysis. Gastroenterology 1994; 106: A141
   Google Scholar